MUTZ MITCHELL purchased 46.11K shares of PANDION THERAPEUTICS, INC. on the open market
Open‑market purchase worth $830.0K. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 7/23/2020ACC: 0000899243-20-020215
Director10% Owner
Since Jul 2020
-12.46M
Net shares
Net seller
$830.0K
Total acquired
2
Open market trades
2B · 0S
5
Total transactions
3.10M acquired · 15.55M disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
+3.05M
Price / share
—
Trade value
—
% of position
New position
7/21/2020
0.00→3.05M
Common Stock
Indirect
Shares
+36.11K
Price / share
$18.00
Trade value
$650K
% of position
1.2%
7/21/2020
3.05M→3.09M
Common Stock
Indirect
Shares
+10K
Price / share
$18.00
Trade value
$180K
% of position
New position
7/21/2020
0.00→10K
Total
Net shares
+3.10M
Net value
$830K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 7/21/2020 | C · Conversion | +3.05M | — | — | New position | 0.00 | 3.05M |
| Common Stock Indirect | 7/21/2020 | P · Purchase | +36.11K | $18.00 | $650K | 1.2% | 3.05M | 3.09M |
| Common Stock Indirect | 7/21/2020 | P · Purchase | +10K | $18.00 | $180K | New position | 0.00 | 10K |
| Total | +3.10M | $830K | ||||||
Derivative Transactions2
Series A Preferred Stock
Indirect
Converts to
Common Stock
2.58M shares
Shares
−13.14M
Strike price
Held after
0.00
Exercisable
—
7/21/2020
Series B Preferred Stock
Indirect
Converts to
Common Stock
473.41K shares
Shares
−2.41M
Strike price
Held after
0.00
Exercisable
—
7/21/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Preferred Stock Indirect | Common Stock2.58M shares | 7/21/2020 | C · Conversion | −13.14M | — | 0.00 | |
| Series B Preferred Stock Indirect | Common Stock473.41K shares | 7/21/2020 | C · Conversion | −2.41M | — | 0.00 |